Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

SHA:688016 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	976.56	2,171	2,967	976.89	1,243	1,051
Short-Term Investments	-	-	-	-	-	0.1
Cash & Short-Term Investments	2,142	2,171	2,967	976.89	1,243	1,051
Cash Growth	-14.32%	-26.84%	203.71%	-21.42%	18.26%	18.23%
Accounts Receivable	506.88	254.04	148.09	123.99	73.2	48.79
Other Receivables	5.17	0.84	1.03	0.86	0.71	-
Receivables	512.05	255.12	149.37	125.27	74.05	48.83
Inventory	242.81	266.4	210.89	155.97	106.92	82.06
Other Current Assets	27.26	48.04	38.06	36.2	34.42	14.53
Total Current Assets	2,924	2,740	3,365	1,294	1,459	1,197
Property, Plant & Equipment	646.08	411.76	335.32	225.84	117.12	53.56
Long-Term Investments	-	-	121.86	125.98	-	-
Goodwill	472.15	435.88	-	-	-	-
Other Intangible Assets	430.96	440.25	207.63	219.29	76.07	60.62
Long-Term Deferred Tax Assets	33.18	22.93	19.53	10.38	13.65	7.29
Long-Term Deferred Charges	185.28	185.98	173.99	97.42	78.7	50.31
Other Long-Term Assets	41.02	54.64	22.63	21.87	9.4	7.57
Total Assets	4,732	4,292	4,246	1,995	1,754	1,376
Accounts Payable	71.89	41.27	40.4	42.13	24.79	17.83
Accrued Expenses	47.51	154.27	137.32	78.07	95.14	80.34
Short-Term Debt	-	14	-	-	-	-
Current Portion of Leases	11.68	12.89	11.38	9.09	8.84	-
Current Income Taxes Payable	34.73	10.78	27.34	9.66	10.71	5.8
Current Unearned Revenue	3.34	4.57	1.86	2.53	2.16	2.72
Other Current Liabilities	445.87	101.26	94.47	45.36	20.4	7.97
Total Current Liabilities	615.02	339.04	312.76	186.83	162.05	114.66
Long-Term Leases	5.31	13.97	24.37	32.09	36.97	-
Long-Term Unearned Revenue	77.39	59.1	37.88	27.25	24.61	22.13
Long-Term Deferred Tax Liabilities	44.66	49.36	-	-	-	-
Other Long-Term Liabilities	7.69	7.65	7.62	6.32	7.84	5.3
Total Liabilities	750.07	469.13	382.63	252.49	231.47	142.09
Common Stock	123.26	123.26	82.73	71.98	71.98	71.98
Additional Paid-In Capital	2,666	2,656	2,623	834.99	818.33	809.09
Retained Earnings	1,376	1,147	1,137	809.71	603.98	352.91
Treasury Stock	-232.76	-120	-	-	-	-
Comprehensive Income & Other	24.35	-13.71	1.59	1.99	-	-
Total Common Equity	3,957	3,792	3,844	1,719	1,494	1,234
Minority Interest	25.48	30.63	19.76	23.96	27.81	-
Shareholders' Equity	3,982	3,822	3,864	1,743	1,522	1,234
Total Liabilities & Equity	4,732	4,292	4,246	1,995	1,754	1,376
Total Debt	16.99	40.86	35.75	41.18	45.81	-
Net Cash (Debt)	2,125	2,130	2,931	935.71	1,197	1,051
Net Cash Growth	-14.09%	-27.34%	213.26%	-21.86%	13.90%	18.23%
Net Cash Per Share	17.44	17.26	27.21	8.73	11.17	9.80
Filing Date Shares Outstanding	120.91	122.37	123.26	107.25	107.25	107.25
Total Common Shares Outstanding	120.91	122.37	123.26	107.25	107.25	107.25
Working Capital	2,309	2,401	3,052	1,108	1,297	1,082
Book Value Per Share	32.72	30.99	31.18	16.03	13.93	11.51
Tangible Book Value	3,054	2,916	3,636	1,499	1,418	1,173
Tangible Book Value Per Share	25.26	23.83	29.50	13.98	13.22	10.94
Buildings	-	49.79	50.05	48.34	45.97	43.14
Machinery	-	138.16	99.48	80.2	58.67	36.84
Construction In Progress	-	288.27	205.96	100.65	2.25	2.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.